Acrofacial vitiligo secondary to PI3KCA inhibitor, alpelisib: case report

Hinich, MG; Hijab, A

Hijab, A (通讯作者)，Ziv Med Ctr, Inst Oncol, Safed, Israel.;Hijab, A (通讯作者)，Ziv Med Ctr, Radiotherapy Unit, Safed, Israel.

FRONTIERS IN ONCOLOGY, 2023; 13 ():

Abstract

Alpelisib plus fulvestrant is a valid second or advanced line of treatment for patients with metastatic hormone receptor (HR)-positive, HER2-negative ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索